| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |